Background Non-adherence to treatment could preclude reaching an optimal outcome.
Thirty to 80% of patients with rheumatic and musculoskeletal diseases (RMDs) do not …

Rheumatoid arthritis (RA) management is driven by evidence, and new 2019 EULAR
recommendations help in refining the relevant place of different disease-modifying anti …

Objectives Fatigue is prevalent in people with inflammatory rheumatic and musculoskeletal
diseases (I-RMDs) and recognised as one of the most challenging symptoms to manage …

Objectives To evaluate an intervention to reduce the nocebo effect (NE) when switching from
the originator infliximab (OI) to the infliximab biosimilar SB2 in chronic inflammatory …

Rheumatoid arthritis (RA) is one of the most common immune mediated inflammatory
diseases. People with rheumatoid arthritis present with pain, swelling, and stiffness that …

Objective To analyse how non-adherence to prescribed treatments might be prevented,
screened, assessed and managed in people with rheumatic and musculoskeletal diseases …

Objective To evaluate the impact of a nurse-led program of self-management and self-
assessment of disease activity in axial spondyloarthritis. Methods Prospective, randomized …

Aims To examine the effects of a tailored telehealth educational intervention on medication
adherence and disease activity in discharged patients with rheumatoid arthritis (RA). Design …

Objective To evaluate the effect of a nurse-led patient education on safety skills of patients
with inflammatory arthritis treated with biologic disease-modifying antirheumatic drugs …

Objectives To explore physicians' and nurses' knowledge, attitudes and experiences of
shared decision making (SDM) in rheumatology, to identify barriers and facilitators to SDM …